# CNS Pharmaceuticals, Inc. — Regulation A 1-A/A

CNS Pharmaceuticals, Inc. of HOUSTON, TX filed a Regulation A 1-A/A with the SEC on 2018-10-12. Aggregate offering: $17.3M (Tier 2). Industry: Other.

## Offering

- Filed: 2018-10-12
- Form: 1-A/A
- Accession: 0001683168-18-003041
- Tier: Tier 2
- Total aggregate offering: $17.3M
- Issuer portion: $17.3M
- Price per security: $6.0000
- Securities offered: Equity (common or preferred stock), Security to be acquired upon exercise of option, warrant or other right to acquire security
- Underwriter: Boustead Securities, LLC
- Audit status: Audited
- Auditor: GBH CPAs, PC
- Jurisdictions: 102 states/territories

## Issuer

- CIK: 0001729427
- Organized in: NV
- Incorporated: 2017
- Address: 2100 WEST LOOP SOUTH, HOUSTON, TX, 77027
- Phone: 800-946-9185
- Employees: 4 part-time

## Financial snapshot (as filed)

- Total assets: $915K
- Cash & equivalents: $381K
- Total liabilities: $1.1M
- Stockholder equity: $-184K
- Net income: $-567K

## People (1)

| Name | Role | Location |
| --- | --- | --- |
| Matthew Lourie | Signer | The Woodlands, TX |

## Other Reg A filings by this issuer (3)

| Filed | Form |
| --- | --- |
| [2018-10-26](https://search.stillhousedata.com/rega/0001683168-18-003156) | 1-A/A |
| [2018-09-10](https://search.stillhousedata.com/rega/0001683168-18-002664) | 1-A/A |
| [2018-06-15](https://search.stillhousedata.com/rega/0001683168-18-001713) | 1-A |

## More

- [CIK 1729427 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1729427&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/rega/0001683168-18-003041.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.